Kane Biotech Expands U.S. Footprint with Distribution Deal
Kane Biotech announces strategic expansion into U.S. government healthcare markets through partnership with Marathon Medical Corporation and new sales team development.
Category : Biotechnology
SeaStar Medical CEO to Present at Investor Forum March 11
SeaStar Medical Holding Corporation announced CEO Eric Schlorff will participate in a fireside chat at the Life Sciences Investor Forum on March 11, 2026, discussing the company's innovative treatments for critically ill patients.
Asgard Microbes: Clue to Origins of Complex Life
Mysterious Asgard archaea microbes, discovered in deep-sea environments, may hold critical insights into the evolutionary leap from simple to complex cellular life, reshaping our understanding of biology's early history.
Ancient Human-Neanderthal Interbreeding Details Revealed in New Study
A groundbreaking genetic analysis provides fresh insights into the complex mating patterns between early humans and Neanderthals, shedding light on our evolutionary history.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
PyroGenesis Confirms Successful Battery Recycling Plasma Tests
PyroGenesis Inc. has completed a primary testing campaign with a leading battery recycler, confirming plasma technology viability for recovering key minerals from lithium-ion batteries. The company is now positioned for potential equipment sales.
World-First Gene-Editing Cure for Rare Disease in B.C.
A British Columbia man has been cured of a rare disease through groundbreaking gene-editing technology, marking a global medical milestone with profound implications for future treatments.
Western Researchers Unlock Algae's Potential for Vitamins, Biofuel
A Western University team led by Professor Bodumil Karas is studying diatom genetics, opening doors to innovative uses in nutrition and renewable energy.
GSK Buys Canadian Drug for $950M to Boost Pipeline
GSK PLC has agreed to purchase Canadian biotech firm 35Pharma Inc. for US$950 million, acquiring an early-stage pulmonary hypertension drug called HS235. The deal comes as CEO Luke Miels works to expand GSK's portfolio ahead of key patent expirations.
Ancient Cheetah DNA Reveals Surprising Evolutionary Insights
Scientists have extracted DNA from mummified cheetah remains found in a hyper-arid cave, uncovering unexpected genetic details that reshape our understanding of the species' history and adaptation.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Kane Biotech's revyve Gel Study Published in Wound Journal
Kane Biotech announces the publication of a peer-reviewed article on its revyve Antimicrobial Wound Gel in the International Wound Journal, highlighting its efficacy and safety.
BioNTech Sues Moderna for Patent Infringement on COVID Shots
BioNTech has initiated a legal action against Moderna, alleging patent infringement related to their COVID-19 vaccine technologies, marking a significant dispute in the pharmaceutical industry.
Kane Biotech Expands US Presence with Distribution Deals
Kane Biotech Inc. has signed non-exclusive distribution agreements with Patient Care Medical and Life Biologics to expand commercial activities for its revyve Antimicrobial Wound Gel products in the United States.
Stoked Bio Licenses Crohn's Disease Therapy Enterololin
Canadian biotech firm Stoked Bio has obtained exclusive global rights from McMaster University to develop Enterololin, a novel narrow-spectrum antibiotic with potential applications for Crohn's disease treatment.
Urine Concentration Key to Clean Energy, McGill Research Shows
A McGill University study finds that higher urine concentrations in microbial fuel cells significantly improve electricity generation, offering sustainable solutions for wastewater treatment and off-grid power.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
McGill Scientists Optimize Urine-to-Energy Conversion Process
Researchers at McGill University in Montreal have announced a breakthrough in converting human urine into usable energy, potentially offering a sustainable waste-to-power solution.
Moderna Beats Revenue Estimates on COVID Shot Sales
Biotechnology firm Moderna exceeded quarterly revenue expectations, driven by resilient sales of its COVID-19 vaccines, highlighting ongoing market demand.
Kane Biotech Restarts Commercial Activities with New Leadership
Kane Biotech announces the resumption of commercial activities for its revyve Antimicrobial Wound Gel line in the U.S. and Canada, alongside key executive appointments to drive North American business development.
Moderna Shares Fall as FDA Rejects Flu Vaccine Review
Moderna's stock price declined following the FDA's decision not to review its new flu vaccine application, impacting investor confidence in the biotech firm's pipeline.
BioAro's AI Longevity Bioactives Approved in UAE
BioAro Inc. secures UAE regulatory approval for its AI-enabled BioActive Longevity Stack, marking a strategic expansion into the Middle East market with personalized health solutions.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Man Pays $50K to Clone His Deceased Boston Terrier
A Miami resident has cloned his beloved Boston Terrier, Lucas, after the dog died from lymphoma, using advanced biotechnology to preserve their bond.
Lilly to Buy Orna Therapeutics for Up to $2.4B
Pharmaceutical giant Eli Lilly announces a major acquisition of therapy developer Orna Therapeutics, with the deal potentially reaching $2.4 billion in value.
HPQ Silicon Confirms Commercial Grade Fumed Silica Production
HPQ Silicon Inc. announces independent verification that its pilot-scale fumed silica reactor produces material meeting commercial grade 150 specifications, replicating earlier lab results.
Ardena Divests Swedish API Site to Nanologica
Ardena has finalized the sale of its Södertälje drug substance manufacturing facility in Sweden to Nanologica AB, with the site reverting to its original name Syntagon AB.
Ottawa Partnership Creates Biotherapeutics and Biodefence Hub
A new partnership between The Ottawa Hospital and University of Ottawa will relocate and expand biotherapeutics manufacturing, positioning Ottawa as a Canadian leader in medical research and biodefence capabilities.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
Free Guide to Prevent THC Vape Oil Discoloration Released
Abstrax publishes a free 30-page guide offering cannabis-derived solution to prevent and reverse vape oil oxidation, addressing industry-wide discoloration issues.
Montreal microbiologist turns pandemic hobby into full-time career
Chloé Savard, a Montreal microbiologist, has built a following of one million on Instagram by sharing stunning microscopic art from her home lab, transforming a pandemic hobby into a thriving career.
Medicenna's MDNA11 Shows Best-in-Class Potential in Cancer Trials
Medicenna Therapeutics provides a 2026 outlook, highlighting strong clinical data for MDNA11 in advanced cancer and plans for a new bifunctional therapy, MDNA113. Read the latest on these Canadian biotech advancements.
Nvidia, Eli Lilly Launch $1B AI Drug Discovery Lab
Nvidia commits $1 billion to a joint AI laboratory with pharmaceutical giant Eli Lilly, aiming to automate and accelerate drug discovery. The Silicon Valley facility will bridge AI and lab science.
HydroGraph Expands Graphene Collaboration as Tier 1 GEIC Member
HydroGraph Clean Power deepens its partnership with the University of Manchester's Graphene Engineering Innovation Centre, gaining a dedicated lab and accelerating commercial projects. Discover the impact on North American innovation.
This Free Telegram App Replaces Your Messy Shopping Notes
Shared lists with real-time sync. No signup needed — just open and shop together.
Recommended
HPQ Silicon's 2025 Focus on Commercialization
HPQ Silicon Inc. reports a year of strategic realignment, technical validation for its fumed silica reactor, and a clear path to revenue. Read about their 2025 progress.
Page 2 of 3
